{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:43:41Z","timestamp":1791323021526,"version":"4.3.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"internal funding in the framework of the clinical laboratory"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00702-021-02443-8","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T06:03:13Z","timestamp":1642485793000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt\u2013Jakob disease in clinical practice"],"prefix":"10.1007","volume":"129","author":[{"given":"Martin","family":"Fayolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-562X","authenticated-orcid":false,"given":"Sylvain","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"2443_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.648743","volume":"15","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Parchi P (2021) Cerebrospinal fluid and blood neurofilament light chain protein in prion disease and other rapidly progressive dementias: current state of the art. Front Neurosci 15:648743. https:\/\/doi.org\/10.3389\/fnins.2021.648743","journal-title":"Front Neurosci"},{"key":"2443_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3233\/JAD-160740","volume":"55","author":"S Abu Rumeileh","year":"2017","unstructured":"Abu Rumeileh S, Lattanzio F, Stanzani Maserati M, Rizzi R, Capellari S, Parchi P (2017) Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and A\u03b242 in the differential diagnosis of creutzfeldt-jakob disease from Alzheimer\u2019s disease with emphasis on atypical disease variants. J Alzheimers Dis 55:1471\u20131480. https:\/\/doi.org\/10.3233\/JAD-160740","journal-title":"J Alzheimers Dis"},{"key":"2443_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/jnnp-2020-323826","volume":"91","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh S, Baiardi S, Ladogana A, Zenesini C, Bartoletti-Stella A, Poleggi A et al (2020) Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease. J Neurol Neurosurg Psychiatry 91:1181\u20131188. https:\/\/doi.org\/10.1136\/jnnp-2020-323826","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2443_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/00365513.2020.1740939","volume":"80","author":"L Agnello","year":"2020","unstructured":"Agnello L, Piccoli T, Vidali M, Cuffaro L, Lo Sasso B, Iacolino G et al (2020) Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis. Scand J Clin Lab Invest 80:313\u2013317. https:\/\/doi.org\/10.1080\/00365513.2020.1740939","journal-title":"Scand J Clin Lab Invest"},{"key":"2443_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner T, Zetterberg H, Teunissen CE, Ostlund RE, Militello M, Andreasson U et al (2016) Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimers Dement 12:517\u2013526. https:\/\/doi.org\/10.1016\/j.jalz.2015.09.009","journal-title":"Alzheimers Dement"},{"key":"2443_CR6","first-page":"1147","volume":"16","author":"K Blennow","year":"2005","unstructured":"Blennow K, Johansson A, Zetterberg H (2005) Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Int J Mol Med 16:1147\u20131149","journal-title":"Int J Mol Med"},{"key":"2443_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.519","journal-title":"Annu Rev Neurosci"},{"key":"2443_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66090-x","author":"C Delaby","year":"2020","unstructured":"Delaby C, Alcolea D, Carmona-Iragui M, Ill\u00e1n-Gala I, Morenas-Rodr\u00edguez E, Barroeta I et al (2020) Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-66090-x","journal-title":"Sci Rep"},{"key":"2443_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116971","volume":"415","author":"L Foucault-Fruchard","year":"2020","unstructured":"Foucault-Fruchard L, Delaye JB, Morange V, Beaufils E, Duwicquet C, Quadrio I et al (2020) An automated alert system based on the p-Tau\/Tau ratio to quickly inform health professionals upon a suspected case of sporadic Creutzfeldt-Jakob disease. J Neurol Sci 415:116971. https:\/\/doi.org\/10.1016\/j.jns.2020.116971","journal-title":"J Neurol Sci"},{"key":"2443_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14\u20133-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924\u2013930. https:\/\/doi.org\/10.1056\/NEJM199609263351303","journal-title":"N Engl J Med"},{"key":"2443_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cca.2019.04.081","volume":"495","author":"S Lehmann","year":"2019","unstructured":"Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M et al (2019) Diagnosis associated with Tau higher than 1200 pg\/mL: insights from the clinical and laboratory practice. Clin Chim Acta 495:451\u2013456. https:\/\/doi.org\/10.1016\/j.cca.2019.04.081","journal-title":"Clin Chim Acta"},{"key":"2443_CR12","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s12035-017-0479-5","volume":"55","author":"F Llorens","year":"2018","unstructured":"Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N et al (2018) Validation of \u03b1-Synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease. Mol Neurobiol 55:2249\u20132257. https:\/\/doi.org\/10.1007\/s12035-017-0479-5","journal-title":"Mol Neurobiol"},{"key":"2443_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00415-019-09610-8","volume":"267","author":"F Llorens","year":"2020","unstructured":"Llorens F, Villar-Piqu\u00e9 A, Hermann P, Schmitz M, Goebel S, Waniek K et al (2020) Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14\u20133-3. J Neurol 267:543\u2013550. https:\/\/doi.org\/10.1007\/s00415-019-09610-8","journal-title":"J Neurol"},{"key":"2443_CR14","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2015.8.FOCUS15328","volume":"39","author":"M Manix","year":"2015","unstructured":"Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda B et al (2015) Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus 39:E2. https:\/\/doi.org\/10.3171\/2015.8.FOCUS15328","journal-title":"Neurosurg Focus"},{"key":"2443_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/wnl.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P et al (2002) Tau protein and 14\u20133-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197. https:\/\/doi.org\/10.1212\/wnl.58.2.192","journal-title":"Neurology"},{"key":"2443_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144. https:\/\/doi.org\/10.1126\/science.6801762","journal-title":"Science"},{"key":"2443_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H et al (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 8:343\u2013347. https:\/\/doi.org\/10.1038\/sj.mp.4001220","journal-title":"Mol Psychiatry"},{"key":"2443_CR18","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","volume":"53","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M et al (2016) Validation of 14\u20133-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic. Mol Neurobiol 53:2189\u20132199. https:\/\/doi.org\/10.1007\/s12035-015-9167-5","journal-title":"Mol Neurobiol"},{"key":"2443_CR19","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","volume":"72","author":"CL Sutphen","year":"2015","unstructured":"Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG et al (2015) Longitudinal cerebrospinal fluid biomarker changes in preclinical alzheimer disease during middle age. JAMA Neurol 72:1029\u20131042. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1285","journal-title":"JAMA Neurol"},{"key":"2443_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.clineuro.2004.12.002","volume":"107","author":"B Van Everbroeck","year":"2005","unstructured":"Van Everbroeck B, Boons J, Cras P (2005) Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 107:355\u2013360. https:\/\/doi.org\/10.1016\/j.clineuro.2004.12.002","journal-title":"Clin Neurol Neurosurg"},{"key":"2443_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneurol.2016.65","volume":"12","author":"G Zanusso","year":"2016","unstructured":"Zanusso G, Monaco S, Pocchiari M, Caughey B (2016) Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol 12:325\u2013333. https:\/\/doi.org\/10.1038\/nrneurol.2016.65","journal-title":"Nat Rev Neurol"},{"key":"2443_CR22","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668. https:\/\/doi.org\/10.1093\/brain\/awp191","journal-title":"Brain"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02443-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:11:35Z","timestamp":1645614695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2443"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02443-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the dosages are covered by the prescription of the physicians for CJD detection. The Biobank was officially registered and ethically approved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}